TransEnterix, Inc. (NYSEAMERICAN:TRXC)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $0.28, but opened at $0.27. TransEnterix shares last traded at $0.26, with a volume of 38,982 shares traded.
A number of equities research analysts have issued reports on the stock. Royal Bank of Canada lowered shares of TransEnterix from an “outperform” rating to a “sector perform” rating and set a $1.00 price target on the stock. in a report on Thursday, August 8th. Zacks Investment Research lowered shares of TransEnterix from a “hold” rating to a “sell” rating in a report on Thursday, October 10th.
TransEnterix (NYSEAMERICAN:TRXC) last announced its quarterly earnings results on Tuesday, November 12th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). The business had revenue of $2.02 million for the quarter, compared to analyst estimates of $4.68 million.
About TransEnterix (NYSEAMERICAN:TRXC)
TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.
Featured Story: Certificate of Deposit (CD) For Risk Adverse Investors?
Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.